Clobetasol Propionate ointment application to grafted burn wound

use of a super potent corticosteroid ointment (Clobetasol Propionate 0.05%) on grafted burn wounds. Clobetasol Propionate ointment applied as the treatment and a common moisturizing ointment as the control. Dosage of treatment is half fingertip unit i.e.0.25g once daily for 8 weeks, self-administered by participants. Each patient acts as their own control, by applying the treatment or placebo to a randomized site 1 or 2(crossover). Participants being asked to wash their hands between application of the two ointments to avoid mixing the effect of the two ointments. The investigator will decide anatomical location of two comparable areas of 3cmx3cm that are accessible for self application of ointment and will mark them as site 1 and site 2. The jars marked A and B, will be prepared by company and the content is unknown to the investigator and the participant. The investigator then randomly allocate which jar on which site using procedure such as coin-tossing . Then the record for each participant will be made giving code number to the participant. (e.g. 001, jar A- site 1, jar B- site 2). There is no break in-between application of two ointments during the 8 weeks trial. The two ointments will be applied at the same time for 8 weeks on their allocated sites for comparison record.